Silence Therapeutics Plc American Depository Share (SLN) is a publicly traded Healthcare sector company. As of May 20, 2026, SLN trades at $6.24 with a market cap of $294.27M and a P/E ratio of -11.51. SLN moved +7.97% today. Year to date, SLN is +5.23%; over the trailing twelve months it is +21.40%. Its 52-week range spans $1.97 to $20.48. Analyst consensus is buy with an average price target of $27.59. Rallies surfaces SLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SLN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SLN recently traded at $6.24. Market cap is $294.27M. P/E ratio is -11.51. Revenue is $839.00K.
| Metric | Value |
|---|---|
| Price | $6.24 |
| Market Cap | $294.27M |
| P/E Ratio | -11.51 |
| EPS | $-0.54 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.48 |
| 52-Week Low | $1.97 |
| Volume | 158.89K |
| Avg Volume | 0 |
| Revenue (TTM) | $839.00K |
| Net Income | $-75.04M |
| Gross Margin | 79.50% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $559.00K | $-88.61M | $-0.63 |
5 analysts cover SLN: 0 strong buy, 4 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.59.